Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and B-Reference-Cited by-同舟云学术

Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and B

Published:2020-04 Issue:3 Volume:31 Page:186-192
ISSN:0957-5235
Container-title:Blood Coagulation & Fibrinolysis
language:en
Short-container-title:

Author:

Chhabra Amit,Spurden Dean,Fogarty Patrick F.,Tortella Bartholomew J.,Rubinstein Emily,Harris Simon,Pleil Andreas M.,Mellor Jennifer,de Courcy Jonathan,Alvir José

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology,General Medicine

Reference26 articles.

1. Guidelines for the management of hemophilia;Srivastava;Haemophilia,2013

2. The past and future of haemophilia: diagnosis, treatments, and its complications;Peyvandi;Lancet,2016

3. Confirmation of longer FIX activity half-life with prolonged sample collection after single doses of nonacog alfa in patients with haemophilia B;Hua;Thromb Haemost,2017

4. Recombinant factor VIII Fc fusion protein: extended-interval dosing maintains low bleeding rates and correlates with von Willebrand factor levels;Shapiro;J Thromb Haemost,2014

5. Outcome of clinical trials with new extended half-life FVIII/IX concentrates;Mancuso;J Clin Med,2017

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human plasma cells engineered to secrete bispecifics drive effective in vivo leukemia killing;Molecular Therapy;2024-08

2. Cost-Effectiveness of Recombinant Factor IX Fc Prophylaxis and Recombinant Factor IX On-Demand Treatment in Patients with Haemophilia B Without Inhibitors;Advances in Therapy;2024-04-23

3. Cost-Effectiveness Analysis of Etranacogene Dezaparvovec Versus Extended Half-Life Prophylaxis for Moderate-to-Severe Haemophilia B in Germany;PharmacoEconomics - Open;2024-03-23

4. An observational study of haemophilia A patients without inhibitors using the French national claims (SNDS) database;Hematology;2024-03-06

5. The current challenges faced by people with hemophilia B;European Journal of Haematology;2023-12-11